APO Research

APO RESEARCH · REPORT

Track-and-Trace and Serialization for Drug

Selected research

Market Structure

Global Track-and-Trace and Serialization for Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Track-and-Trace and Serialization for Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Track-and-Trace and Serialization for Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Track-and-Trace and Serialization for Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Track-and-Trace and Serialization for Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Track-and-Trace and Serialization for Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Track-and-Trace and Serialization for Drug include Bosch Packaging, SAP, Axway, Xyntec Inc, SoftGroup, TraceLink and Infosys, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Track-and-Trace and Serialization for Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Track-and-Trace and Serialization for Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Track-and-Trace and Serialization for Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Track-and-Trace and Serialization for Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Track-and-Trace and Serialization for Drug Segment by Company

Bosch Packaging

SAP

Axway

Xyntec Inc

SoftGroup

TraceLink

Infosys

Track-and-Trace and Serialization for Drug Segment by Type

Cloud-based

On-premise

Track-and-Trace and Serialization for Drug Segment by Application

Biopharmaceutical

Chemical Pharmaceutical

Track-and-Trace and Serialization for Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Track-and-Trace and Serialization for Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Track-and-Trace and Serialization for Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Track-and-Trace and Serialization for Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Track-and-Trace and Serialization for Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Track-and-Trace and Serialization for Drug industry.

Chapter 3: Detailed analysis of Track-and-Trace and Serialization for Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Track-and-Trace and Serialization for Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Track-and-Trace and Serialization for Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cloud-based Table 3. Key Players of On-premise Table 4. Global Track-and-Trace and Serialization for Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Biopharmaceutical Table 6. Key Players of Chemical Pharmaceutical Table 7. Global Track-and-Trace and Serialization for Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Track-and-Trace and Serialization for Drug Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Track-and-Trace and Serialization for Drug Market Share by Region (2021-2026) Table 10. Global Track-and-Trace and Serialization for Drug Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Track-and-Trace and Serialization for Drug Market Share by Region (2027-2032) Table 12. Track-and-Trace and Serialization for Drug Industry Trends Table 13. Track-and-Trace and Serialization for Drug Industry Drivers Table 14. Track-and-Trace and Serialization for Drug Industry Opportunities and Challenges Table 15. Track-and-Trace and Serialization for Drug Industry Restraints Table 16. Global Track-and-Trace and Serialization for Drug Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Company (2021-2026) Table 18. Global Track-and-Trace and Serialization for Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Track-and-Trace and Serialization for Drug Key Company Head Office and Area Served Table 20. Global Track-and-Trace and Serialization for Drug Company, Product Type & Application Table 21. Global Track-and-Trace and Serialization for Drug Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Track-and-Trace and Serialization for Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Track-and-Trace and Serialization for Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Type (2021-2026) Table 28. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Type (2027-2032) Table 29. Global Track-and-Trace and Serialization for Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Application (2021-2026) Table 33. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Application (2027-2032) Table 34. Bosch Packaging Company Information Table 35. Bosch Packaging Business Overview Table 36. Bosch Packaging Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Bosch Packaging Track-and-Trace and Serialization for Drug Product Portfolio Table 38. Bosch Packaging Recent Development Table 39. SAP Company Information Table 40. SAP Business Overview Table 41. SAP Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. SAP Track-and-Trace and Serialization for Drug Product Portfolio Table 43. SAP Recent Development Table 44. Axway Company Information Table 45. Axway Business Overview Table 46. Axway Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Axway Track-and-Trace and Serialization for Drug Product Portfolio Table 48. Axway Recent Development Table 49. Xyntec Inc Company Information Table 50. Xyntec Inc Business Overview Table 51. Xyntec Inc Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Xyntec Inc Track-and-Trace and Serialization for Drug Product Portfolio Table 53. Xyntec Inc Recent Development Table 54. SoftGroup Company Information Table 55. SoftGroup Business Overview Table 56. SoftGroup Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. SoftGroup Track-and-Trace and Serialization for Drug Product Portfolio Table 58. SoftGroup Recent Development Table 59. TraceLink Company Information Table 60. TraceLink Business Overview Table 61. TraceLink Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. TraceLink Track-and-Trace and Serialization for Drug Product Portfolio Table 63. TraceLink Recent Development Table 64. Infosys Company Information Table 65. Infosys Business Overview Table 66. Infosys Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Infosys Track-and-Trace and Serialization for Drug Product Portfolio Table 68. Infosys Recent Development Table 69. North America Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026) & (US$ Million) Table 70. North America Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032) & (US$ Million) Table 71. North America Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026) & (US$ Million) Table 72. North America Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032) & (US$ Million) Table 73. North America Track-and-Trace and Serialization for Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Track-and-Trace and Serialization for Drug Market Size by Country (2021-2026) Table 75. North America Track-and-Trace and Serialization for Drug Market Size by Country (2027-2032) Table 76. Europe Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026) & (US$ Million) Table 77. Europe Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032) & (US$ Million) Table 78. Europe Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026) & (US$ Million) Table 79. Europe Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032) & (US$ Million) Table 80. Europe Track-and-Trace and Serialization for Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Europe Track-and-Trace and Serialization for Drug Market Size by Country (2021-2026) Table 82. Europe Track-and-Trace and Serialization for Drug Market Size by Country (2027-2032) Table 83. China Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026) & (US$ Million) Table 84. China Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032) & (US$ Million) Table 85. China Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026) & (US$ Million) Table 86. China Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032) & (US$ Million) Table 87. Asia Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026) & (US$ Million) Table 88. Asia Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032) & (US$ Million) Table 89. Asia Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026) & (US$ Million) Table 90. Asia Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032) & (US$ Million) Table 91. Asia Track-and-Trace and Serialization for Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Asia Track-and-Trace and Serialization for Drug Market Size by Country (2021-2026) Table 93. Asia Track-and-Trace and Serialization for Drug Market Size by Country (2027-2032) Table 94. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026) & (US$ Million) Table 95. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032) & (US$ Million) Table 96. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026) & (US$ Million) Table 97. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032) & (US$ Million) Table 98. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Country (2021-2026) Table 100. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Country (2027-2032) Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Track-and-Trace and Serialization for Drug Product Image Figure 2. Global Track-and-Trace and Serialization for Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Track-and-Trace and Serialization for Drug Market Share by Type: 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-premise Image Figure 6. Global Track-and-Trace and Serialization for Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Track-and-Trace and Serialization for Drug Market Share by Application: 2025 VS 2032 Figure 8. Biopharmaceutical Image Figure 9. Chemical Pharmaceutical Image Figure 10. Global Track-and-Trace and Serialization for Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 12. Global Track-and-Trace and Serialization for Drug Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Track-and-Trace and Serialization for Drug Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Track-and-Trace and Serialization for Drug Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Track-and-Trace and Serialization for Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Type (2021-2032) Figure 19. Global Track-and-Trace and Serialization for Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Application (2021-2032) Figure 21. North America Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 22. North America Track-and-Trace and Serialization for Drug Market Share by Type (2021-2032) Figure 23. North America Track-and-Trace and Serialization for Drug Market Share by Application (2021-2032) Figure 24. North America Track-and-Trace and Serialization for Drug Market Share by Country (2021-2032) Figure 25. United States Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 26. Canada Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 28. Europe Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 29. Europe Track-and-Trace and Serialization for Drug Market Share by Type (2021-2032) Figure 30. Europe Track-and-Trace and Serialization for Drug Market Share by Application (2021-2032) Figure 31. Europe Track-and-Trace and Serialization for Drug Market Share by Country (2021-2032) Figure 32. Germany Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 33. France Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 35. Italy Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 36. Russia Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 38. China Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 39. China Track-and-Trace and Serialization for Drug Market Share by Type (2021-2032) Figure 40. China Track-and-Trace and Serialization for Drug Market Share by Application (2021-2032) Figure 41. Asia Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 42. Asia Track-and-Trace and Serialization for Drug Market Share by Type (2021-2032) Figure 43. Asia Track-and-Trace and Serialization for Drug Market Share by Application (2021-2032) Figure 44. Asia Track-and-Trace and Serialization for Drug Market Share by Country (2021-2032) Figure 45. Japan Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 49. India Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 50. Australia Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Share by Country (2021-2032) Figure 55. Brazil Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 60. UAE Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 62. Chile Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Biopharmaceutical
  • Chemical Pharmaceutical
Companies covered
  • Bosch Packaging
  • SAP
  • Axway
  • Xyntec Inc
  • SoftGroup
  • TraceLink
  • Infosys

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Track-and-Trace and Serialization for Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-premise
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Track-and-Trace and Serialization for Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Biopharmaceutical
  9. 1.3.3 Chemical Pharmaceutical
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Track-and-Trace and Serialization for Drug Growth Trends by Region
  12. 1.5.1 Global Track-and-Trace and Serialization for Drug Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Track-and-Trace and Serialization for Drug Market Size by Region (2021-2026)
  14. 1.5.3 Track-and-Trace and Serialization for Drug Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Track-and-Trace and Serialization for Drug Market Dynamics
  1. 2.1 Track-and-Trace and Serialization for Drug Industry Trends
  2. 2.2 Track-and-Trace and Serialization for Drug Industry Drivers
  3. 2.3 Track-and-Trace and Serialization for Drug Industry Opportunities and Challenges
  4. 2.4 Track-and-Trace and Serialization for Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Track-and-Trace and Serialization for Drug Revenue by Company (2021-2026)
  2. 3.2 Global Track-and-Trace and Serialization for Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Track-and-Trace and Serialization for Drug Key Company Head office and Area Served
  4. 3.4 Global Track-and-Trace and Serialization for Drug Company, Product Type & Application
  5. 3.5 Global Track-and-Trace and Serialization for Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Track-and-Trace and Serialization for Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Track-and-Trace and Serialization for Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Track-and-Trace and Serialization for Drug Tier 1, Tier 2, and Tier 3
4 Track-and-Trace and Serialization for Drug Market by Type
  1. 4.1 Global Track-and-Trace and Serialization for Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Track-and-Trace and Serialization for Drug Market Size by Type (2021-2032)
  3. 4.3 Global Track-and-Trace and Serialization for Drug Market Size Share by Type (2021-2032)
5 Track-and-Trace and Serialization for Drug Market by Application
  1. 5.1 Global Track-and-Trace and Serialization for Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Track-and-Trace and Serialization for Drug Market Size by Application (2021-2032)
  3. 5.3 Global Track-and-Trace and Serialization for Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bosch Packaging
  2. 6.1.1 Bosch Packaging Company Information
  3. 6.1.2 Bosch Packaging Business Overview
  4. 6.1.3 Bosch Packaging Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bosch Packaging Track-and-Trace and Serialization for Drug Product Portfolio
  6. 6.1.5 Bosch Packaging Recent Developments
  7. 6.2 SAP
  8. 6.2.1 SAP Company Information
  9. 6.2.2 SAP Business Overview
  10. 6.2.3 SAP Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 SAP Track-and-Trace and Serialization for Drug Product Portfolio
  12. 6.2.5 SAP Recent Developments
  13. 6.3 Axway
  14. 6.3.1 Axway Company Information
  15. 6.3.2 Axway Business Overview
  16. 6.3.3 Axway Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Axway Track-and-Trace and Serialization for Drug Product Portfolio
  18. 6.3.5 Axway Recent Developments
  19. 6.4 Xyntec Inc
  20. 6.4.1 Xyntec Inc Company Information
  21. 6.4.2 Xyntec Inc Business Overview
  22. 6.4.3 Xyntec Inc Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Xyntec Inc Track-and-Trace and Serialization for Drug Product Portfolio
  24. 6.4.5 Xyntec Inc Recent Developments
  25. 6.5 SoftGroup
  26. 6.5.1 SoftGroup Company Information
  27. 6.5.2 SoftGroup Business Overview
  28. 6.5.3 SoftGroup Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 SoftGroup Track-and-Trace and Serialization for Drug Product Portfolio
  30. 6.5.5 SoftGroup Recent Developments
  31. 6.6 TraceLink
  32. 6.6.1 TraceLink Company Information
  33. 6.6.2 TraceLink Business Overview
  34. 6.6.3 TraceLink Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 TraceLink Track-and-Trace and Serialization for Drug Product Portfolio
  36. 6.6.5 TraceLink Recent Developments
  37. 6.7 Infosys
  38. 6.7.1 Infosys Company Information
  39. 6.7.2 Infosys Business Overview
  40. 6.7.3 Infosys Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Infosys Track-and-Trace and Serialization for Drug Product Portfolio
  42. 6.7.5 Infosys Recent Developments
7 North America
  1. 7.1 North America Track-and-Trace and Serialization for Drug Market Size (2021-2032)
  2. 7.2 North America Track-and-Trace and Serialization for Drug Market Size by Type
  3. 7.2.1 North America Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Track-and-Trace and Serialization for Drug Market Share by Type (2021-2032)
  6. 7.3 North America Track-and-Trace and Serialization for Drug Market Size by Application
  7. 7.3.1 North America Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Track-and-Trace and Serialization for Drug Market Share by Application (2021-2032)
  10. 7.4 North America Track-and-Trace and Serialization for Drug Market Size by Country
  11. 7.4.1 North America Track-and-Trace and Serialization for Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Track-and-Trace and Serialization for Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Track-and-Trace and Serialization for Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Track-and-Trace and Serialization for Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Track-and-Trace and Serialization for Drug Market Size (2021-2032)
  2. 8.2 Europe Track-and-Trace and Serialization for Drug Market Size by Type
  3. 8.2.1 Europe Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Track-and-Trace and Serialization for Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Track-and-Trace and Serialization for Drug Market Size by Application
  7. 8.3.1 Europe Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Track-and-Trace and Serialization for Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Track-and-Trace and Serialization for Drug Market Size by Country
  11. 8.4.1 Europe Track-and-Trace and Serialization for Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Track-and-Trace and Serialization for Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Track-and-Trace and Serialization for Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Track-and-Trace and Serialization for Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Track-and-Trace and Serialization for Drug Market Size (2021-2032)
  2. 9.2 China Track-and-Trace and Serialization for Drug Market Size by Type
  3. 9.2.1 China Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Track-and-Trace and Serialization for Drug Market Share by Type (2021-2032)
  6. 9.3 China Track-and-Trace and Serialization for Drug Market Size by Application
  7. 9.3.1 China Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Track-and-Trace and Serialization for Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Track-and-Trace and Serialization for Drug Market Size (2021-2032)
  2. 10.2 Asia Track-and-Trace and Serialization for Drug Market Size by Type
  3. 10.2.1 Asia Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Track-and-Trace and Serialization for Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Track-and-Trace and Serialization for Drug Market Size by Application
  7. 10.3.1 Asia Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Track-and-Trace and Serialization for Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Track-and-Trace and Serialization for Drug Market Size by Country
  11. 10.4.1 Asia Track-and-Trace and Serialization for Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Track-and-Trace and Serialization for Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Track-and-Trace and Serialization for Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Track-and-Trace and Serialization for Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Track-and-Trace and Serialization for Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research